Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study
Myers, Andrea P., Filiaci, Virginia L., Zhang, Yuping, Pearl, Michael, Behbakht, Kian, Makker, Vicky, Hanjani, Parviz, Zweizig, Susan, Burke, James J., Downey, Gordon, Leslie, Kimberly K., Van HummeleVolume:
141
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2016.02.025
Date:
April, 2016
Fichier:
PDF, 883 KB
2016
File converter
Plus de résultats de recherche
More benefits 
